S&T GLOBAL INC has a total of 17 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, China and Australia. Its main competitors in its focus markets pharmaceuticals and biotechnology are MAGAININ SCIENCES INC, PODACK ECKHARD R and CYTOVATION AS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | China | 3 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Brazil | 1 | |
#7 | Taiwan | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Su Zhuang | 16 |
#2 | Yang Suizhou | 15 |
#3 | Long Zhengyu | 15 |
#4 | Huang Zhennian | 7 |
#5 | Suizhou Yang | 1 |
#6 | Long Zheng-Yu | 1 |
#7 | Zhengyu Long | 1 |
#8 | Zhennian Huang | 1 |
#9 | Zhuang Su | 1 |
#10 | Yang Sui-Zhou | 1 |
Publication | Filing date | Title |
---|---|---|
CA3024320A1 | Novel cyclosporin derivatives and uses thereof | |
CN105960246A | Novel cyclosporin derivatives and uses thereof | |
US2013210704A1 | Cyclosporin derivatives and uses thereof | |
AU2011336266A1 | Novel cyclosporin derivatives for the treatment and prevention of a viral infection |